Engagement of the α2β1 integrin by stromal VCAM1 and activation of CXCR4 together promote survival signaling via the Syk tyrosine kinase in chronic lymphocytic leukemia (CLL). The gene discussed is VCAM1; the disease is B-cell chronic lymphocytic leukemia.